These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 546424)

  • 1. Enzymatic hydrolysis of pentaerythritoltetranicotinate and meso-inositolhexanicotinate in blood and tissues.
    Harthon L; Brattsand R
    Arzneimittelforschung; 1979; 29(12):1859-62. PubMed ID: 546424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of plasma levels of free nicotinic acid in rats and rabbits treated with nicotinic acid, pentaerythritol tetranicotinate (Perycit) and 2,6-pyridine dimethanol dinicotinoate.
    Testa R; Gambini M; Canestrini C
    Farmaco Prat; 1978 Nov; 33(11):463-71. PubMed ID: 750231
    [No Abstract]   [Full Text] [Related]  

  • 3. The behavior of pentaerythritol tetranicotinate in rat gastrointestinal tract as a prodrug.
    Takikawa K; Miyazaki K; Arita T
    J Pharmacobiodyn; 1981 Feb; 4(2):123-30. PubMed ID: 7277198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption and excretion of radioactive pentaerythritoltetranicotinate, mesoinositolhexanicotinate and nicotinic acid after oral administration to cat.
    Brattsand R; Harthon L
    Arzneimittelforschung; 1971 Sep; 21(9):1335-8. PubMed ID: 5171788
    [No Abstract]   [Full Text] [Related]  

  • 5. [Resorption, blood levels and elimination of meso-inositol-14C-hexanicotinate following oral administration to cats].
    Brattgård SO; Brattsand R; Harthon JG
    Arzneimittelforschung; 1966 Feb; 16(2):145-6. PubMed ID: 6014006
    [No Abstract]   [Full Text] [Related]  

  • 6. Some aspects of sorbinicate pharmacokinetics.
    Subissi A; Biagi M; Murmann W
    Arzneimittelforschung; 1980; 30(8):1278-84. PubMed ID: 7192142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption in rats, dogs, pigs, and humans of nicotinic acid after oral administration of phosphatidyl inositol pentanicotinate hydrochloride (PIN).
    Hertle H; Kiese M; Renner G
    Arzneimittelforschung; 1979; 29(1):114-6. PubMed ID: 582105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the absorption, excretion and metabolism of pentaerythritoltetranicotinate.
    Harthon L; Sigroth K
    Arzneimittelforschung; 1974 Oct; 24(10):1688-92. PubMed ID: 4373013
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolism of niflumic acid-14C: absorption, excretion and biotransformation by human and dog.
    Lan SJ; Chando TJ; Weliky I; Schreiber EC
    J Pharmacol Exp Ther; 1973 Aug; 186(2):323-30. PubMed ID: 4719785
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
    Artery; 1982; 10(4):266-85. PubMed ID: 7181672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [On the uptake and effect of hexanicotinic acid-esters of meso-inosit in the body].
    Brandt H; Fromm H
    Dtsch Med J; 1966 Mar; 17(6):176-8. PubMed ID: 5973781
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute effects on plasma lipids in the rat of a new long-acting nicotinic acid derivative: LG 13979.
    Subissi A; Criscuoli M; Biagi M; Murmann W
    J Pharm Pharmacol; 1983 Sep; 35(9):571-5. PubMed ID: 6138406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of nimodipine. I. Communication: absorption, concentration in plasma and excretion after single administration of [14C]nimodipine in rat, dog and monkey.
    Maruhn D; Siefert HM; Weber H; Rämsch K; Suwelack D
    Arzneimittelforschung; 1985; 35(12):1781-6. PubMed ID: 4096729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical properties of blood esmolol esterase.
    Quon CY; Stampfli HF
    Drug Metab Dispos; 1985; 13(4):420-4. PubMed ID: 2863104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A promising codrug of nicotinic acid and ibuprofen for managing dyslipidemia. I: synthesis and in vitro evaluation.
    Abu Zanat FZ; Qandil AM; Tashtoush BM
    Drug Dev Ind Pharm; 2011 Sep; 37(9):1090-9. PubMed ID: 21401343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of different dose regimens of niceritrol of serum lipid concentrations in man.
    Rössner S; Olsson AG; Orö L
    Acta Med Scand; 1976; 200(4):269-71. PubMed ID: 983794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biotransformation and pharmacokinetics of inositol hexanicotinate in rats.
    Milton SG; Robinson K; Ma J; Wei B; Poon IO; Liang D
    Xenobiotica; 2013 Sep; 43(9):817-22. PubMed ID: 23347001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and plasma binding of diazepam in man, dog, rabbit, guinea pig and rat.
    Klotz U; Antonin KH; Bieck PR
    J Pharmacol Exp Ther; 1976 Oct; 199(1):67-73. PubMed ID: 789856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antilipidemic drugs. Part 4: The metabolic fate of the hypolipidemic agent isopropyl-[4'-(p-chlorobenzoyl)-2-phenoxy-2-methyl]-protionate (LF 178) in rats, dog and man.
    Brodie RR; Chasseaud LF; Elson FF; Franklin ER; Taylor T
    Arzneimittelforschung; 1976; 26(5):896-901. PubMed ID: 989365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of amezinium in rat and dog.
    Traut M; Brode E; Neumann B; Kummer H
    Arzneimittelforschung; 1981; 31(9a):1594-604. PubMed ID: 7197974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.